Transo-Pharm focus on APIs for the generic market; a distinctive offer has been built by this privately owned company over many years. Their unique capability to offer regulatory support, combined with the shared service provided by our Chemical and Regulatory experts, means that our clients are supported within the framework of ever increasing regulation.
About this product
Antifibrinolytic Agent / Haemostatic, suitable for injectable applications
1197-18-8